Aurobindo Pharma arm extends negotiations deadline with MSD for contract manufacturing operations

Aurobindo Pharma extends deadline for CuraTeQ Biologics and Merck Sharp & Dohme Singapore negotiations on contract manufacturing operations at TheraNym Biologics Pvt Ltd for US biopharmaceutical company till May 2024.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ROH2bJE
via IFTTT